| Non-inferiority Trial of Locally Manufactured Typhoid Conjugate Vaccine 'Typhocon' in Bangladesh (NCT05475379) | International Centre for Diarrhoeal Disease Research, Bangladesh | 2022-07-01 |
| Transcriptomic Responses for the Identification of Pathogens (NCT04878549) | University of Sheffield | 2022-05-02 |
| Immune Equivalence Between Multi-dose and Single Dose Formulation of Vi-DT and Their Overall Safety (Phase III) (NCT04204096) | International Vaccine Institute | 2020-02-04 |
| Immune Non-inferiority and Safety of a Vi-DT Typhoid Conjugate Vaccine (NCT03933098) | International Vaccine Institute | 2019-11-15 |
| Typhoid Conjugate Vaccine Trial Among Children Younger Than 2 Years in Ouagadougou, Burkina Faso (NCT03614533) | University of Maryland, Baltimore | 2018-12-03 |
| Safety, Reactogenicity and Immunogenicity of Vi-DT;Typhoid Conjugate Vaccine (NCT03527355) | International Vaccine Institute | 2018-04-18 |
| Clinical Efficacy of Typhoid Conjugate Vaccine (Vi-TCV) Among Children Age 9 Months Through 12 Years in Blantyre, Malawi (NCT03299426) | University of Maryland, Baltimore | 2018-02-21 |
| Effects of Aging on Primary and Secondary Vaccine Responses (NCT03312699) | Stanford University | 2017-09-19 |
| Safety and Immunogenicity of a Vi-DT Typhoid Conjugate Vaccine (NCT02645032) | International Vaccine Institute | 2016-05-19 |
| A Phase 3b, Randomized, Open-Label Study to Evaluate the Safety and Immunogenicity of Select Travel Vaccines When Administered Concomitantly With MenACWY in Adults (NCT01466387) | Novartis | 2011-11-01 |
| Understanding Typhoid Disease After Vaccination (NCT01405521) | University of Oxford | 2011-10-07 |
| Immunogenicity, Safety and Tolerability of the Typhoid Fever Vaccine Candidate M01ZH09 in Healthy Adults (NCT00679172) | Emergent BioSolutions | 2008-05-01 |
| Studies of Immune Responses to Orally Administered Vaccines in Developing Country (NCT01019083) | International Centre for Diarrhoeal Disease Research, Bangladesh | 2008-02-01 |
| Evaluation of the Vi Polysaccharide Vaccine Against Typhoid Fever (NCT00125008) | International Vaccine Institute | 2003-05-01 |
| Introduction of the Vi Polysaccharide Typhoid Vaccine in Hue City, Central Vietnam (NCT00131820) | International Vaccine Institute | 2001-12-01 |
| Combined Vi Vaccination and Health Education Program on the Burden of Typhoid in Childhood (NCT00125047) | International Vaccine Institute | 2001-10-01 |
| Typhoid Vi Vaccine Effectiveness in Hechi, Guangxi, China (NCT00131833) | International Vaccine Institute | 2001-10-01 |